Fibrocell Science, Inc. (FCSC) SEC Filing 8-K Material Event for the period ending Thursday, October 25, 2018

Fibrocell Science, Inc.

CIK: 825788 Ticker: FCSC

View differences made from one to another to evaluate Fibrocell Science, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Fibrocell Science, Inc..


Assess how Fibrocell Science, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Fibrocell Science, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Fibrocell Science, Inc. provided additional information to their SEC Filing as exhibits

Ticker: FCSC
CIK: 357097
Form Type: 8-K Corporate News
Accession Number: 0001628280-18-012890
Submitted to the SEC: Thu Oct 25 2018 8:06:24 AM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Thursday, October 25, 2018
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: